Wall Street Zen upgraded shares of Nukkleus (NASDAQ:NUKK - Free Report) from a sell rating to a hold rating in a research report sent to investors on Friday.
Nukkleus Stock Down 6.6%
NUKK stock traded down $1.00 during midday trading on Friday, hitting $14.25. The stock had a trading volume of 165,844 shares, compared to its average volume of 1,395,466. The stock has a 50-day simple moving average of $14.78 and a 200 day simple moving average of $16.72. Nukkleus has a 52 week low of $1.30 and a 52 week high of $78.32.
Nukkleus (NASDAQ:NUKK - Get Free Report) last released its quarterly earnings data on Friday, May 23rd. The company reported $18.19 earnings per share (EPS) for the quarter.
Institutional Trading of Nukkleus
A hedge fund recently bought a new stake in Nukkleus stock. XTX Topco Ltd bought a new stake in Nukkleus Inc. (NASDAQ:NUKK - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,490 shares of the company's stock, valued at approximately $125,000. XTX Topco Ltd owned approximately 0.22% of Nukkleus as of its most recent filing with the Securities and Exchange Commission (SEC). 12.47% of the stock is currently owned by institutional investors.
About Nukkleus
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Featured Stories
Before you consider Nukkleus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.
While Nukkleus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
